For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Centene CorporationCNC US · Health Care · USD Current price$65.58as of Nov 20, 2026 Summary
Analyst consensusStrong Buy 1Buy 7Hold 12Sell 118 analysts 3-year price (USD)Factor profileMulti-factor score 84 / 100 Market data
Business descriptionLargest U.S. Medicaid managed care organization (about 11.9M members; Medicaid about 52% of 2025 premium revenue), also serving ACA Marketplace and Medicare Advantage/Part D. Sub-industry: Managed Health Care; S&P 500, Large-Cap Value. Competitive moatScale in government programs gives pricing leverage with providers, and ongoing vertical integration adds cost advantages. Risk is concentrated in a limited number of state contracts and government funding. Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Nov 13, 2026
Current price: $65.58 · Nov 20, 2026· USD
CFRA Ratingbuy
TBI Multi Score84
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: CNCBusiness description
Largest U.S. Medicaid managed care organization (about 11.9M members; Medicaid about 52% of 2025 premium revenue), also serving ACA Marketplace and Medicare Advantage/Part D. Sub-industry: Managed Health Care; S&P 500, Large-Cap Value.
Competitive moat
Scale in government programs gives pricing leverage with providers, and ongoing vertical integration adds cost advantages. Risk is concentrated in a limited number of state contracts and government funding.
Recent developments
- Q3 2026: 2026 adjusted EPS guide raised to above USD 5.20 (from 4.80), after a 71% Y/Y adjusted EPS fall to USD 2.08 in 2025. HBR guided to 90.4-91.1% (80-150 bps better).
- MA now expected to break even in 2026, a year early; ACA Marketplace pretax margin at the top of the 4.5-5% range (vs -1% in 2025).
- Voluntary separation program: headcount -11.5% Y/Y to 53,900, USD 276M Q3 severance.
- Medicaid membership loss estimate raised to 8-9% for 2026 (from 6%); management sees margin improvement over 12-16 months.
- Sector read: Managed Health Care Q3 2026 Earnings & Post-Midterm Policy.
Investment risks / red flags
- OBBBA Medicaid cuts and work requirements (no later than 01/01/2027) vs the highest Medicaid weight among large peers.
- Utilization and acuity mix after membership declines; competition for contracts.
- Stars: only 42% of members in plans rated 3.5 or higher.
Market Data
Source: mkts.io · Nov 20, 2026, 14:01 UTC
Key Metrics
P/E (TTM)22.54
P/E (Fwd)11.77
Dividend0.00%
Beta1.08
52W High$78.08
52W Low$31.63
Analyst Consensus
7
12
Strong Buy1Buy7Hold12Sell118 analysts
Consensus Target$76.11
+16.1% upside
Calendar Events
Next EarningsOct 27, 2026
Financials
Revenue$180.41B
Rev Growth0.20%
Gross Margin11.34%
Op Margin1.92%
Profit Margin0.81%
EBITDA$4.69B
ROA2.68%
ROE6.74%
Rev/Share$366.02
Total Cash$23.59B
Total Debt$15.54B
D/E Ratio69.67
Free Cash Flow$3.08B
Op Cash Flow$4.72B
Current Ratio1.16
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | -1.15 | $46.21B |
| +1q | 3.37 | $48.86B |
| 0y | 5.29 | $200.22B |
| +1y | 5.57 | $195.59B |
Earnings
Quarterly EPS
4Q2025
Est: -1.22-1.19Beat
1Q2026
Est: 2.133.37Beat
2Q2026
Est: 1.082.51Beat
3Q2026
Est: 0.100.58Beat
Annual
2022
Rev $144.55BEarn $1.20B
2023
Rev $154.00BEarn $2.70B
2024
Rev $163.07BEarn $3.31B
2025
Rev $194.78BEarn -$6.67B
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 2, 2026 | Truist Securities | reit | Buy |
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight |
| Oct 29, 2026 | JP Morgan | main | Neutral |
| Oct 28, 2026 | UBS | main | Neutral |
| Oct 28, 2026 | Morgan Stanley | main | Equal-Weight |
| Oct 28, 2026 | Barclays | main | Overweight |
